WebDec 1, 2024 · Ibrexafungerp is the first and only FDA-approved antifungal to both treat vulvovaginal candidiasis (VVC) and prevent recurrent VVC. The approval comes on the PDUFA date for non-azole oral ibrexafungerp tablets, which are marketed under the commercial name Brexafemme. WebJun 7, 2024 · On the GoodRx website generic fluconazole sells for $30. Generic miconazole, which can be obtained without a prescription, costs about half of that at …
GSK and SCYNEXIS Announce an Exclusive Agreement to
WebIbrexafungerp, sold under the brand name Brexafemme, is an antifungal medication used to treat vulvovaginal candidiasis (VVC) (vaginal yeast infection). [1] It is taken orally (by mouth). [1] It is also currently undergoing clinical trials for other indications via an intravenous (IV) formulation. WebJun 3, 2024 · Brexafemme is a new, one-day oral antifungal medication and it's now FDA-approved to treat vulvovaginal candidiasis (vaginal yeast infections). blackwood wellness
CENTER FOR DRUG EVALUATION AND RESEARCH - Food and …
WebNov 30, 2024 · 2.1 Recommended Dosage Treatment of VVC: The recommended dosage of BREXAFEMME in adult and post-menarchal pediatric females is 300 mg (two 150 mg tablets) administered approximately 12 hours apart (e.g., in the morning and in the evening) for one day, for a total daily dosage of 600 mg (four 150 mg tablets). Reduction in the … WebBREXAFEMME prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects. WebApr 1, 2024 · Brexafemme; Descriptions. Ibrexafungerp is used to treat fungal or yeast infections, including vulvovaginal candidiasis. It is also used to reduce the risk of the vulvovaginal candidiasis infection coming back. This medicine works by killing the fungus or yeast, or preventing its growth. black wood western thriller saban films